search
Back to results

FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing (FFP3-RAE)

Primary Purpose

Eustachian Tube Dysfunction, Hearing Disorders, Nasal Obstruction

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
FFP3 Mask
Sponsored by
Liverpool University Hospitals NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Eustachian Tube Dysfunction focused on measuring FFP3M respirators, eustachian tube dysfunction, hearing loss, audiometry, tympanometry

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthcare workers that already have their own masks, fitted and provided by the Trust for day-to-day clinical use
  • Participants without pre-existing sinonasal symptoms or previous sinonasal surgery
  • Participants without pre-existing hearing loss or a history of otological procedures

Exclusion Criteria:

  • Participants with pre-existing sinonasal symptoms or previous sinonasal surgery
  • Participants with pre-existing hearing loss or a history of otological procedures
  • Participants who do not satisfy the requirements set out in the pre-registration questionnaire

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    FFP3 Respirator

    Arm Description

    Participants will wear FFP3 respirators during the study.

    Outcomes

    Primary Outcome Measures

    Changes in baseline pure tone audiometry post intervention.
    We will measure changes in baseline pure tone audiometry post FFP3 respirator usage..
    Measurement of speech attenuation in decibels.
    We will measure speech attenuation in decibels when participants are wearing FFP3 respirators
    Changes in baseline tympanometry post intervention
    We will measure changes in baseline tympanometry post FFP3 respirator usage.

    Secondary Outcome Measures

    Eustachian tube function
    Participants will complete the SINO-NASAL OUTCOME TEST (SNOT-22) Questionnaire which is a 22 point questionnaire. Participants will be asked to grade the severity of their symptoms from 1-5 with with higher scores denoting severe symptoms. The questionnaires will be completed pre and post interventions to investigate changes in eustachian tube function.
    Eustachian tube function
    Participants will complete the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) which is a 7 point questionnaire. Patients are asked to grade the severity of their symptoms from 1-7 with with higher scores denoting severe symptoms. The questionnaires will be completed pre and post interventions to investigate changes in eustachian tube function.

    Full Information

    First Posted
    September 20, 2021
    Last Updated
    May 27, 2022
    Sponsor
    Liverpool University Hospitals NHS Foundation Trust
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05222230
    Brief Title
    FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing
    Acronym
    FFP3-RAE
    Official Title
    FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    July 23, 2022 (Anticipated)
    Primary Completion Date
    December 31, 2022 (Anticipated)
    Study Completion Date
    December 31, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Liverpool University Hospitals NHS Foundation Trust

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This is Prospective Basic Science Study whose aims are as follows: To determine the effect of Filtering Facepiece (FFP3M) respirators on eustachian tube function and hearing To evaluate the extent to which FFP3M respirators attenuate speech in decibels The outcome measures are as follows: Changes in baseline pure tone audiometry and tympanometry post intervention. SNOT-22 Questionnaires before and after use of respirator ETDQ7 questionnaire Measurement of speech attenuation in decibels.
    Detailed Description
    The use of facemasks is one of the key strategies for reducing human to human transmission of SARS-CoV-2. There is a variety of facemasks worn in the clinical environment ranging from simple facemasks to devices such as filtering face piece 3M (FFP3M) respirators which are mandatory for some clinicians performing aerosol generating procedures (AGPs.) It has been shown that wearing face protective equipment attenuates sound causing decay in speech intelligibility, especially transmission of middle-to-high voice frequencies.It has been shown that wearing surgical masks results in up to 23.3% loss of speech intelligibility in noisy environments with advanced face personal protective equipment such as FFP3M devices, accounting for up to 69.0% reduction of speech intelligibility. A reduction in speech intelligibility leads to reduced understanding which may result in miscommunication thereby compromising patient safety. To date, there have been two critical incidents in our department due to miscommunication attributed to wearing FFP3M respirators. Anecdotally, clinicians have reported nasal congestion and subjective hearing loss during FFP3M respirator usage and after, especially when they are worn for a prolonged period of time. Clinicians working in theatre may be required to wear these devices for a number of hours when involved with AGPs. The secondary consequences of wearing FFP3M respirators for prolonged periods of time, especially in a theatre setting require scientific exploration. This study aims to investigate the effect of FFP3M respirators on middle ear pressure and hearing, and the extent to which FFP3M respirators attenuate sound. Investigators believe that a reduction in speech intelligibility is not the only explanation for the perception of hearing loss when using FFP3M respirators. Investigators postulate that a transient dysfunction in the eustachian tube pressure regulating system also contributes to hearing loss. To test this hypothesis, investigators will measure hearing and middle ear pressure using pure tone audiometry and tympanometry before and during FFP3M usage. Investigators will also use SNOT-22 and ETDQ7 questionnaires which are validated patient reported outcome measures for nasal symptoms and eustachian tube function. Investigators hope that this study provides some understanding of the physiological effects of FFP3M respirators on hearing and sinonasal symptoms and improves our understanding of their impact on clinical practice. There are no current studies looking into the effects of FFP3M respirators on eustachian tube function.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Eustachian Tube Dysfunction, Hearing Disorders, Nasal Obstruction
    Keywords
    FFP3M respirators, eustachian tube dysfunction, hearing loss, audiometry, tympanometry

    7. Study Design

    Primary Purpose
    Basic Science
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Prospective open label basic science study.
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    12 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    FFP3 Respirator
    Arm Type
    Experimental
    Arm Description
    Participants will wear FFP3 respirators during the study.
    Intervention Type
    Other
    Intervention Name(s)
    FFP3 Mask
    Intervention Description
    Participans will wear FFP3 respirators during the study.
    Primary Outcome Measure Information:
    Title
    Changes in baseline pure tone audiometry post intervention.
    Description
    We will measure changes in baseline pure tone audiometry post FFP3 respirator usage..
    Time Frame
    48 hours
    Title
    Measurement of speech attenuation in decibels.
    Description
    We will measure speech attenuation in decibels when participants are wearing FFP3 respirators
    Time Frame
    1 hours
    Title
    Changes in baseline tympanometry post intervention
    Description
    We will measure changes in baseline tympanometry post FFP3 respirator usage.
    Time Frame
    48 hours
    Secondary Outcome Measure Information:
    Title
    Eustachian tube function
    Description
    Participants will complete the SINO-NASAL OUTCOME TEST (SNOT-22) Questionnaire which is a 22 point questionnaire. Participants will be asked to grade the severity of their symptoms from 1-5 with with higher scores denoting severe symptoms. The questionnaires will be completed pre and post interventions to investigate changes in eustachian tube function.
    Time Frame
    48 hours
    Title
    Eustachian tube function
    Description
    Participants will complete the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) which is a 7 point questionnaire. Patients are asked to grade the severity of their symptoms from 1-7 with with higher scores denoting severe symptoms. The questionnaires will be completed pre and post interventions to investigate changes in eustachian tube function.
    Time Frame
    48 hours

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Healthcare workers that already have their own masks, fitted and provided by the Trust for day-to-day clinical use Participants without pre-existing sinonasal symptoms or previous sinonasal surgery Participants without pre-existing hearing loss or a history of otological procedures Exclusion Criteria: Participants with pre-existing sinonasal symptoms or previous sinonasal surgery Participants with pre-existing hearing loss or a history of otological procedures Participants who do not satisfy the requirements set out in the pre-registration questionnaire
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Nazia Munir, FRCS ORL-HNS
    Phone
    07970921448
    Email
    nazir.munir@liverpoolft.nhs.uk
    First Name & Middle Initial & Last Name or Official Title & Degree
    Todd Kanzara, FRCS ORL-HNS
    Phone
    07796945100
    Email
    todd.kanzara@nhs.net

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    No data will be shared with other researchers
    Citations:
    PubMed Identifier
    33138498
    Citation
    Corey RM, Jones U, Singer AC. Acoustic effects of medical, cloth, and transparent face masks on speech signals. J Acoust Soc Am. 2020 Oct;148(4):2371. doi: 10.1121/10.0002279.
    Results Reference
    background
    PubMed Identifier
    33389012
    Citation
    Muzzi E, Chermaz C, Castro V, Zaninoni M, Saksida A, Orzan E. Short report on the effects of SARS-CoV-2 face protective equipment on verbal communication. Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3565-3570. doi: 10.1007/s00405-020-06535-1. Epub 2021 Jan 3.
    Results Reference
    background
    PubMed Identifier
    32641175
    Citation
    Hampton T, Crunkhorn R, Lowe N, Bhat J, Hogg E, Afifi W, De S, Street I, Sharma R, Krishnan M, Clarke R, Dasgupta S, Ratnayake S, Sharma S. The negative impact of wearing personal protective equipment on communication during coronavirus disease 2019. J Laryngol Otol. 2020 Jul;134(7):577-581. doi: 10.1017/S0022215120001437. Epub 2020 Jul 28.
    Results Reference
    background
    PubMed Identifier
    19793277
    Citation
    Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009 Oct;34(5):447-54. doi: 10.1111/j.1749-4486.2009.01995.x.
    Results Reference
    background
    PubMed Identifier
    22374681
    Citation
    McCoul ED, Anand VK, Christos PJ. Validating the clinical assessment of eustachian tube dysfunction: The Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Laryngoscope. 2012 May;122(5):1137-41. doi: 10.1002/lary.23223. Epub 2012 Feb 28.
    Results Reference
    background

    Learn more about this trial

    FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing

    We'll reach out to this number within 24 hrs